Cargando…
Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a global pandemic. The hyperglycemia in patients with diabetes mellitus (DM) substantially compromises their innate immune system. SARS-CoV-2 uses human angiotensin-c...
Autores principales: | Liao, Yu-Huang, Zheng, Jing-Quan, Zheng, Cai-Mei, Lu, Kuo-Cheng, Chao, You-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762278/ https://www.ncbi.nlm.nih.gov/pubmed/33297431 http://dx.doi.org/10.3390/jcm9123962 |
Ejemplares similares
-
Novel Evidence of Acute Kidney Injury in COVID-19
por: Chueh, Ti-I, et al.
Publicado: (2020) -
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
por: Ho, Ping, et al.
Publicado: (2021) -
Molecular biomarkers for gestational diabetes mellitus and postpartum diabetes
por: Lu, Wenqian, et al.
Publicado: (2022) -
Metabolic Acidosis and Strong Ion Gap in Critically Ill Patients with Acute Kidney Injury
por: Zheng, Cai-Mei, et al.
Publicado: (2014) -
Corrigendum to “Metabolic Acidosis and Strong Ion Gap in Critically Ill Patients with Acute Kidney Injury”
por: Zheng, Cai-Mei, et al.
Publicado: (2018)